Kintara Therapeutics Reports 10 Months Progression-Free Survival in Newly-Diagnosed MGMT-unmethylated GBM from Ongoing MD Anderson Cancer Center Phase 2 Study

Nov 19, 2020

Kintara Therapeutics Announces First Fiscal Quarter 2021 Financial Results and Recent Corporate Updates

Nov 13, 2020

Kintara and the Global Coalition for Adaptive Research Execute Agreement for VAL-083's Participation in the GBM AGILE Registrational Study

Oct 21, 2020

Kintara Therapeutics Announces Fiscal Year 2020 Financial Results and Recent Corporate Updates

Sep 21, 2020

Kintara Therapeutics Completes Final Closing of Previously Announced Private Placement For an Aggregate of $25 Million

Sep 1, 2020

Kintara Therapeutics (formerly DelMar Pharmaceuticals) to Present at the LD Micro 500 Virtual Conference on September 3rd, 2020

Aug 26, 2020

Kintara Therapeutics Announces Closing of Additional $2.2 Million Private Placement Priced at the Market

Aug 25, 2020

Kintara Therapeutics Announces Additional $2.4 Million Private Placement Priced At-The-Market

Aug 21, 2020

Kintara Therapeutics (formerly DelMar Pharmaceuticals) Regains Compliance with NASDAQ Minimum Bid Price Requirement

Aug 21, 2020

Kintara Therapeutics (Formerly DelMar Pharmaceuticals) Announces Completion of Merger with Adgero Biopharmaceuticals and Closing of $19.6 Million Private Placement Priced At-The-Market

Aug 20, 2020